In type I blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), eyelid abnormalities are associated with ovarian failure. Type II BPES shows only the eyelid defects, but both types map to chromosome 3q23. We have positionally cloned a novel, putative winged helix/forkhead transcription factor gene, FOXL2, that is mutated to produce truncated proteins in type I families and larger proteins in type II. Consistent with an involvement in those tissues, FOXL2 is selectively expressed in the mesenchyme of developing mouse eyelids and in adult ovarian follicles; in adult humans, it appears predominantly in the ovary. FOXL2 represents a candidate gene for the polled/intersex syndrome XX sex-reversal goat
The FOXL2 gene is one of 10 forkhead genes, the mutations of which lead to human developmental disor...
The FOXL2 gene is one of 10 forkhead genes, the mutations of which lead to human developmental disor...
International audience: FOXL2 is a gene encoding a forkhead transcription factor preferentially expr...
In type I blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), eyelid abnormalities are asso...
The Blepharophimosis Ptosis Epicanthus-inversus Syndrome is a genetic disease characterized by compl...
International audienceThe Blepharophimosis Ptosis Epicanthus-inversus Syndrome is a genetic disease ...
The Blepharophimosis Ptosis Epicanthus-inversus Syndrome is a genetic disease characterized by compl...
Mutations in FOXL2, a forkhead transcription factor gene, have recently been shown to cause blepharo...
Mutations in FOXL2, a forkhead transcription factor gene, have recently been shown to cause blepharo...
Mutations in FOXL2, a forkhead transcription factor gene, have recently been shown to cause blepharo...
Mutations in the forkhead transcription factor gene 2 (FOXL2) were recently reported to cause blepha...
Abstract Background Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is a rare inherita...
Background: Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is an autosomal dominant d...
FOXL2 mutations cause the autosomal dominant Blepharophimosis-ptosis-epicanthus inversus syndrome (B...
FOXL2 mutations cause the autosomal dominant Blepharophimosis-ptosis-epicanthus inversus syndrome (B...
The FOXL2 gene is one of 10 forkhead genes, the mutations of which lead to human developmental disor...
The FOXL2 gene is one of 10 forkhead genes, the mutations of which lead to human developmental disor...
International audience: FOXL2 is a gene encoding a forkhead transcription factor preferentially expr...
In type I blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), eyelid abnormalities are asso...
The Blepharophimosis Ptosis Epicanthus-inversus Syndrome is a genetic disease characterized by compl...
International audienceThe Blepharophimosis Ptosis Epicanthus-inversus Syndrome is a genetic disease ...
The Blepharophimosis Ptosis Epicanthus-inversus Syndrome is a genetic disease characterized by compl...
Mutations in FOXL2, a forkhead transcription factor gene, have recently been shown to cause blepharo...
Mutations in FOXL2, a forkhead transcription factor gene, have recently been shown to cause blepharo...
Mutations in FOXL2, a forkhead transcription factor gene, have recently been shown to cause blepharo...
Mutations in the forkhead transcription factor gene 2 (FOXL2) were recently reported to cause blepha...
Abstract Background Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is a rare inherita...
Background: Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is an autosomal dominant d...
FOXL2 mutations cause the autosomal dominant Blepharophimosis-ptosis-epicanthus inversus syndrome (B...
FOXL2 mutations cause the autosomal dominant Blepharophimosis-ptosis-epicanthus inversus syndrome (B...
The FOXL2 gene is one of 10 forkhead genes, the mutations of which lead to human developmental disor...
The FOXL2 gene is one of 10 forkhead genes, the mutations of which lead to human developmental disor...
International audience: FOXL2 is a gene encoding a forkhead transcription factor preferentially expr...